Instructional Video4:40
Instructional Video3:14
Curated Video

China reports 425 deaths in virus outbreak

Higher Ed
China's health authorities announced the latest figures of 425 deaths and 20,438 confirmed infections of a viral outbreak, up from 361 deaths and 17,205 cases the previous day.
Instructional Video2:24
Curated Video

Researchers: virus vaccine will take many months

Higher Ed
French researchers who are working to develop a vaccine against the new coronavirus say they hope to have it ready and available within the coming 20 months.
Instructional Video3:30
Curated Video

China reports 105 new deaths in virus outbreak

Higher Ed
Chinese authorities on Monday reported a slight rise in cases of the new coronavirus, and 105 more deaths.
Instructional Video2:15
Curated Video

AP Exclusive: Testing COVID-19 vaccine in people

Higher Ed
FOR CLEAN VERSION SEE STORY NUMBER: apus132447
Instructional Video2:17
Curated Video

National Health Commission holds daily briefing

Higher Ed
China on Tuesday reported 21 new cases of the new coronavirus, 20 of them imported.
Instructional Video3:20
Curated Video

WHO chief: World on verge of 100,000 virus cases

Higher Ed
The head of the World Health Organization on Friday said the world was on the verge of reaching 100-thousand confirmed coronavirus cases and urged all nations to make containment their highest priority.
Instructional Video1:48
Curated Video

UK confirms 3,605 deaths from virus

Higher Ed
British Health Secretary Matt Hancock confirmed on Friday that 3,605 people have died in the UK from the new coronavirus.
News Clip2:13
Sky News

Matt Hancock MP daily press briefing on coronavirus

Higher Ed
CLEAN: Interior shots of Health Secretary Matt Hancock MP giving daily Downing Street Press Briefing on coronavirus on 3 April 2020 in London, United Kingdom
Instructional Video3:00
Curated Video

Chinese scientists: vaccine progressing steadily

Higher Ed
Chinese scientists said on Monday that they now have three vaccines at the clinical trials stage, but warned that vaccine development was complicated and that they would welcome global cooperation.
News Clip3:05
Sky News

Coronavirus Testing Trials -- Professor Andrew Pollard Interview

Higher Ed
CLEAN: Interior shots interview with Professor Andrew Pollard, director of the Oxford Vaccine Group about coronavirus vaccine testing on 23 April 2020 in Oxford, United Kingdom.
Instructional Video3:23
Curated Video

Oxford vaccine human trial begins, comment from doctor

Higher Ed
Trials for a new COVID-19 vaccine began on humans at Oxford University in the UK on Thursday.
Instructional Video6:57
Curated Video

DAILY MOFA BRIEFING

Higher Ed
MOFA Briefing
Instructional Video3:00
Curated Video

Chinese scientists: vaccine progressing steadily

Higher Ed
Chinese scientists said on Monday that they now have three vaccines at the clinical trials stage, but warned that vaccine development was complicated and that they would welcome global cooperation.
News Clip2:49
Sky News

Health Secretary Matt Hancock speaks at Downing Street press conference

Higher Ed
CLEAN: Interior shots of Health Secretary Matt Hancock MP speaking a Downing Street Press Conference on coronavirus vaccine prospects on 16 November 2020 in London, United Kingdom
News Clip5:05
Bloomberg

Why No Country Is Safe From the Delta Variant

Higher Ed
Jun.30 -- It is impossible to prevent the Covid-19 delta variant from taking over without a "wall of vaccination," says cell biologist Jennifer Rohn. "I'm afraid no country, even the U.K. which has such a great record, has that wall,"...
News Clip9:34
The Recount

The Research Gap in Women's Health and Fertility

Higher Ed
On this week's "Just Something About Her," Afton Vechery shares how she started the at-home fertility testing company Modern Fertility to de-stigmatize and fill the void of information about women's health – especially reproduction.
News Clip12:26
Bloomberg

Moderna CEO Says Covid-19 Vaccine a ‘Game Changer’

Higher Ed
Nov.16 -- Moderna Chief Executive Officer Stephane Bancel discusses the clinical trial results of its Covid-19 vaccine, efficacy in elderly patients, and efforts to address possible virus mutations on "Bloomberg Markets,"